Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform that redefines the way professionals obtain concise, cited information on…
The post…
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights Read Post »
SELZENTRY (maraviroc) Viiv hlthcare Patent: 7,368,460 Expiration: May 25, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pat…
Drug Patent Expirations for the Week of May 21, 2023 Read Post »
This chart shows the drugs with the most patents in Philippines. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Phi…
Which pharmaceutical drugs have the most drug patents in Philippines? Read Post »
SELZENTRY (maraviroc) Viiv hlthcare Patent: 7,368,460 Expiration: May 25, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pat…
Drug Patent Expirations for the Week of May 21, 2023 Read Post »
This chart shows the pharmaceutical companies with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pa…
Which pharmaceutical companies have the most drug patents in Lithuania? Read Post »
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…
Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Novartis drug PROMACTA appeared f…
New patent expiration for Novartis drug PROMACTA Read Post »
Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Novartis drug PROMACTA KIT appeared f…
New patent expiration for Novartis drug PROMACTA KIT Read Post »
Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Novartis drug PROMACTA KIT appeared f…
New patent expiration for Novartis drug PROMACTA KIT Read Post »
This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suppository dosed drugs…
The post Which pharmaceutical companies have the m…
Which pharmaceutical companies have the most suppository dosed drugs? Read Post »
Get new actionable insights and updates from BiotechBlog
